A study conducted at the University of São Paulo (USP) in Brazil shows that the synthetic molecule Pep19 acts on the endocannabinoid system, which helps regulate and balance key metabolic functions, such as appetite, fat breakdown (lipolysis), and energy release.
You may also be interested in:
A National Institutes of Health clinical trial has found that a monoclonal antibody, mepolizumab, decreased asthma attacks by 27% in Black and Hispanic children and [...]
It’s not the mobile that makes children hyperactive, but the other way round: a fidgety child will use a mobile phone more—according to the latest [...]
A lifeguard shortage in many parts of the U.S. means an increased drowning risk at pools and beaches this summer. Earlier this summer, SciLine interviewed [...]